Former Google CEO Eric Schmidt warns that Artificial Super-intelligence (ASI) could surpass collective human intelligence within six years. Speaking on the Special Competitive Studies Project podcast, ...

Morgan Stanley initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals, flagging divergent business models and upcoming catalysts ...

If we imagine religion as a technology, argues Notre Dame sociologist Christian Smith, we can better see the cause of its ...

Amid claims of "digital dementia," experts explain that AI isn't declining. It's just stupid in the first place.

One of the standout features of Manjaro 25.0 is its enhanced support for Flatpak, a universal package management system. This ...

Traditional verification involves a high degree of manual intervention, especially if the design is constantly evolving. This ...

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- Several experts are seeing that ...

AI-driven cars that drive themselves and earn money, redefining urban mobility and car ownership. Self-driving AI ...

The administration of South Korean President Lee Jae-myung, which has positioned itself as an “artificial intelligence ...

LeetCode is super important for coding interviews because lots of big tech companies use its style of problems. Getting good ...

Universities across the country are scrambling to understand the implications of generative A.I.’s transformation of ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.27, marking a +1.15% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.83%. At ...